LONDON, April 8, 2014 /PRNewswire/ --
The US markets saw a negative sentiment on Monday, April 07, 2014, with the NASDAQ Composite closing at 4,079.75, down 1.16%, the Dow Jones Industrial Average ending the session at 16,245.87, down 1.02%, and the S&P 500 declined 1.08%, to finish the trading session at 1,845.04. The session witnessed selling pressure in the Consumer Discretionary, Financials, and Energy sectors that negatively impacted the broader market. A number of stocks saw large movements, including Banco Bradesco S.A. (NYSE: BBD), RadNet Inc. (NASDAQ: RDNT), Repligen Corp. (NASDAQ: RGEN) and B&G Foods Inc. (NYSE: BGS). Free technical research on BBD, RDNT, RGEN and BGS can be downloaded upon signing up at:
On Monday, shares in Banco Bradesco S.A. ended the session at $14.87, up 5.16%. A total of 16.10 million shares were traded as compared with its three months average volume of 8.89 million shares. During the session, the stock traded between $14.22 and $14.92. Banco Bradesco S.A.'s shares have surged 4.42% in the previous three trading sessions and 26.02% in the last one month, and 18.68% on YTD basis. The S&P 500 Financials Sector Index mapped a loss of 1.49% during the trading session, and the same has charted down 0.41% in the previous three months. Further, the company's stock has a Relative Strength Index (RSI) of 76.96 and is trading above its 50-day and 200-day moving averages of $11.71 and $12.62, respectively. Sign up today to read free research on BBD at:
RadNet Inc.'s stock closed Monday's session at $3.76, which is 8.36% higher than the previous day's closing price of $3.47. The stock oscillated between $3.48 and $3.97 during the trading session with a trading volume of 1.11 million shares, which is above its three months average volume of 0.37 million shares. Shares in RadNet Inc. have rallied 33.33% in the last one month, 133.54% in the previous three months and 125.15% on YTD basis. The S&P 500 Health Care Sector Index mapped a loss of 1.06% during the trading session, while charted up 3.19% in the previous three months. Moreover, the company's stock has an RSI of 81.99 and is trading above its 50-day and 200-day moving average of $2.35 and $2.34, respectively. Sign up today to read free research on RDNT at:
On Monday, Repligen Corp.'s stock surged 6.33%, finishing at $14.10. The stock fluctuated between $13.04 and $14.34 during the session with a trading volume of 1.11 million shares as compared with its three months average volume of 0.51 million shares. Shares in Repligen Corp. have gained 3.91% in the previous three trading sessions, 9.64% in the last three months and 3.37% on YTD basis. The S&P 500 Health Care Index mapped a loss of 1.06% during the trading session and the same has declined 2.85% in the previous three trading sessions. Furthermore, the company's stock has an RSI of 41.46 and is trading above its 200-day moving average of $11.92. Sign up today to read free research on RGEN at:
Shares in B&G Foods Inc. finished Monday's session at $33.47, up 6.02%. A total of 0.79 million shares were traded, which is above its three months average volume of 0.35 million shares. The stock vacillated between $31.65 and $33.62 during the session. Repligen Corp.'s shares have advanced 9.38% in the previous three trading sessions, 10.72% in the last one month, while the same has fallen 1.30% on YTD basis. The S&P 500 Consumer Staples Sector Index mapped a gain of 1.20% in the last one month, while the S&P 500 has declined 1.76% during the same period. Additionally, the company's stock has an RSI of 62.09 and is trading above its 50-day and 200-day moving averages of $30.57 and $33.46, respectively. Sign up today to read free research on BGS at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.